Welcome to ASENT

Abstract Submission

It is time to begin preparing your Abstract Submission the 2019 Annual Meeting. Below you will find our important submission deadlines:

Abstract submission opens: May 1

Abstract submission closes: June 27

ASENT allows the submission of research which has been presented at or submitted to another meeting. Watch this space for more information.

Honors and Awards

Michael S. Okun, M.D., Adelaide Lackner Professor and Chair of Neurology, and Co-director of the Fixel Center for Neurological Diseases at the University of Florida Health College of Medicine, will be honored with the 2018 Presidential Award at the ASENT 20th Annual Meeting, in Rockville, MD, on Saturday, March 10, 2018 at 10:15 am. 


President's Message

Read the latest from our president Martha Morrell, MD, Chief Medical Officer, NeuroPace, Inc., and Clinical Professor of Neurology at Stanford University.



The American Society for Experimental Neurotherapeutics (ASENT) is an independent non-profit organization established in 1997 by leaders in academia, government, advocacy and industry to facilitate the process by which new therapies are made available to patients with neurological disorders. 


Verge Genomics Founder, Alice Zhang to speak at
ASENT 20th Annual Meeting

Alice Zhang


Verge Genomics Founder, Alice Zhang, was recently recognized by Angel.co as one of the 20 top female founders to join in 2018 and was named one of Forbes' 30 under 30. We are thrilled that she has carved time into her busy schedule to speak on Genomic-based drug discovery for neurodegenerative diseases at the ASENT 20th Annual meeting.

If you have not taken a look at the program, you can see it here.

Support Travel Awards in Neurotherapeutics

Jeffrey S. Nye Leadership Fund is a great way for leaders in the field to provide support to trainees who wish to attend the ASENT Annual Meeting. Travel award recipients are selected from abstract submissions.


Clinical Translation Course

The Clinical Translation Course is offered as a pre-meeting symposium just prior to the ASENT Annual Meeting. Some of the topics and speakers include:

Requirements for pharmaceuticals and devices (exclusive of repurposing)
Carlos Peña, PhD, FDA

Identifying Stakeholders in the Healthcare Ecosystem  
Michael Gold, PPD, Global Product Development

SBIR and Other NINDS Funding Opportunities and Resources for Translational Researchers, NIH funding for repurposing drugs 
Amir Tamiz, PhD, NINDS/NIH

These are just a few of the outstanding speakers you can expect at the 2018 Clinical Translation Course. 



Calendar more

The upcoming calendar is currently empty.

Click here to view past events and photos »

  • Discounted registration fee for the ASENT annual meeting (up to a $100 value)
  • Subscription to Neurotherapeutics the journal, a quarterly publication focused on critical reviews of topics essential to current and future central nervous system therapeutics ($150 value)
  • Abstract submissions for presentations through the Annual Meeting and journal ($50 value)
  • Interaction with FDA, NINDS, Industry leadership, Neurology Chairs, Startups, Venture Capital and more (priceless).




Need help renewing your dues? Try this video:

Need help signing in? Check out this short video

A 3½-day short course to introduce academic researchers to the principles
of neurotherapeutic drug discovery and development.

Click here for more information on the application process.

Click here to download a pdf of the application.

2017 ASENT Annual Meeting Supporters